28-Day Study of SAGE-718 on Functioning Capacity in Participants With Huntington's Disease

Summary

The primary purpose of this study is to assess the magnitude of the baseline difference between participants with early Huntington's Disease (HD) and healthy participants (HP) with respect to measures of cognitive performance.

Timeline

Start

2022-05-26

Primary completion

2024-02-29

Completion

2024-04-10

Drugs

Indications